Responsiveness and Minimal Clinically Important Difference (MCID) of Knee Injury and Osteoarthritis (KOOS-12) in (OA)

Superior University

Status: Active, not recruiting

Conditions: Knee Osteoarthritis

Treatments: Diagnostic Test: PT-intervention

Study type: Observational

Funder types: Other

Identifiers

NCT06901921

MSRSW/Batch-Fall23/780

Details and patient eligibility

About

Osteoarthritis (OA) is a common and disabling constant Musculoskeletal Disorder that causes significant weight on individual, Health Care Systems, and social economy. With the maturing of the populace and the commonness of undesirable way of life practices, the predominance and disease burden of OA are expanding day by day. Different non-surgical interventions have been introduced worldwide for the treatment of knee OA. The aim of this study is to determine the responsiveness and minimal clinically important difference for knee injury and osteoarthritis outcome score-12 in knee OA patients respectively.

Enrollment: 60 patients

Sex: All

Ages: 50 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• An Age group of 50-65 years will be included in study.
• both males and females will be included.
• Patients with Unilateral knee OA with K-L grade II-III involving medial side will be a part of study.
• Following ACR (American college of rheumatology) guidelines Patient with knee pain must have 3 or more than 3 of the following symptoms i.e. age >50 years, morning stiffness <30 minutes, crepitus on movement, tenderness, bony enlargements, no palpable warmth will also be a part of study.
• patient having pain ranging from 5-8 on Numeral Pain Rating Scale (NPRS) will be included

Exclusion criteria

• participants with Traumatic knee injuries (cruciate injuries, meniscal injuries etc.) will be excluded.
• Osteonecrosis patients will be excluded.
• Patient with Neurological problems won't be a part of this study.
• People having Metastasis or neoplasm will be omitted.
• Knee or hip fractures
• Rheumatoid arthritis, Systemic lupus erythematosus (SLE) or other autoimmune disease people will be listed out.

Trial design

60 participants in 1 patient group

PT-intervention

Treatment:

Diagnostic Test: PT-intervention